Find here all the news from the CBM and beyond
Filtrer par
Openings for junior scientists or junior group leaders in Chemistry, Biology, Biophysics
Deadline: June 15
Trans-amplifying RNA platform for vaccines and pandemic preparedness - May 21, 2021
Dr Tim Beissert, Johannes Gutenberg University, Mainz, Germany.
Friday, May 21, 2021 at 11 a.m.
Biodiversity skepticism?
J.-M. Bonmatin co-author of a new critical article (5 April 2021)
J.-M. Bonmatin co-author of an article in One Health (18 March 2021)
Study of the impact of biocids on bees with the "One Health" concept
Webconference “Les vaccins à ARN, vers une nouvelle ère de la vaccination” - March 29, 2021
Chantal Pichon, Professor at the University of Orléans and team leader at the CBM, speaks in this webconference organized by the Bio3 Institute of the University of Tours
Webinar "Space Biochemistry at the Interface: Interactions Between Biospheres, Geospheres, And Atmospheres Under Planetary Conditions" - March 26, 2021
Dr Tetyana Milojevic, Space Biochemistry Group, University of Vienna
SFNano Webinar - March 31st, 2021
Webinar on mRNA vaccines
Webinar "RMN solide in vivo pour l'étude de membranes biologiques" - March 19, 2021
Dr Dror WARSCHAWSKI,Laboratoire de Biologie Physico-Chimique des Protéines Membranaires, Paris
J.-M. Bonmatin co-author of a letter in Science
J.-M. Bonmatin and six co-authors have just published a letter in the January 8, 2021 issue of Science magazine, entitled "Stay true to integrated pest management"
Decline in insect populations
J.-M. Bonmatin, co-author of an article in Science (December 18, 2020) questions the conclusions of a study on the decline of insects published in April
Towards new imaging markers for in vivo detection of pathologies such as Alzheimer's or diabetes
Researchers from CBM and LCC (Toulouse) have designed a new probe to detect amyloid deposits biomarkers of these diseases
Neonicotinoids
The link between neoniconitoides and contamination of soils and populations highlighted
Detection of amyloid peptides: biomarkers for Alzheimer’s Disease and Diabetes
The chemists of the “Metal complexes and MRI” research group have developed novel imaging probes which specifically recognise amyloid aggregates, characteristic of Alzheimer’s Disease and Diabetes and gained new insights into their peptide binding mechanisms. These results could facilitate early diagnosis and better molecular understanding of these diseases.
RNA Remodeling Proteins, Methods and Protocols
The second edition, edited by Marc Boudvillain, has just been published
